Clinicopathologic Features of Antibrush Border Antibody Disease
Joel D. Murphy(Arkana Laboratories), Christopher P. Larsen(Arkana Laboratories)
Cited by 7
Related Papers
SARS–CoV-2 infection of the placenta
|Journal of Clinical Investigation|2020|492
Diagnosis of IgG4-Related Tubulointerstitial Nephritis
|Journal of the American Society of Nephrology|2011|374
AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype
|Journal of the American Society of Nephrology|2020|284
LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease
|Journal of the American Society of Nephrology|2017|81